Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd Share Price Today: Live Updates & Key Insights
Get insights on Oxygenta Pharmaceutical Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Oxygenta Pharmaceutical Ltd Share Price Chart
OXYGENTAPHARMA at 10 Jul 2026 05:51 PM Pharmaceuticals
48.25 +2.00(+4.32%)
Lowest Today 46.60
Highest Today 48.74
Today's Open 47.98
Prev. Close 46.25
52 Week High 133.50
52 Week Low 43.00
Oxygenta Pharmaceutical Ltd Fundamentals
Traded Volume: 5,398
Market Cap(Cr): 178.45
Avg Traded Price 47.67
1 Year return -57.68%
Upper Circuit 48.7
Lower Circuit 46.6
P/E TTM 0.00
P/B Ratio -4.008
Traded Value(Cr) 2.60
EPS TTM NaN
Book value/Share -11.540
Dividend Yield 1Y 0.00%
Oxygenta Pharmaceutical Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Oxygenta Pharmaceutical Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Oxygenta Pharmaceutical Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -57.68%
YTD 0.00%
Oxygenta Pharmaceutical Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Oxygenta Pharmaceutical Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Oxygenta Pharmaceutical Ltd Technical Details
Oxygenta Pharmaceutical Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 47
Support 2 46
Support 3 45
Pivot Point : 48
Resistance 1 49
Resistance 2 50
Resistance 3 51
Oxygenta Pharmaceutical Ltd Corporate Actions
Oxygenta Pharmaceutical Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Oxygenta Pharmaceutical Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by OXYGENTAPHARMA
Bonus
No Bonus has been declared by OXYGENTAPHARMA
Splits
No Split has been declared by OXYGENTAPHARMA
Others
Rights No Rights has been declared by OXYGENTAPHARMA
Oxygenta Pharmaceutical Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Oxygenta Pharmaceutical Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Oxygenta Pharmaceutical Ltd's relative performance and valuation against major competitors.
Stock Name Accretion Nutraveda Ltd ₹259.30 (+4.96%) M. Cap (Cr) 1.88 1 Yr Return (%) NaN% P/E (TTM) 37.04 PB Ratio 5.29
Stock Name Sanjivani Paranteral Ltd ₹144.00 (+0.66%) M. Cap (Cr) 1.77 1 Yr Return (%) -34.34% P/E (TTM) 17.96 PB Ratio 3.67
Stock Name Accretion Pharmaceuticals Ltd ₹157.00 (-2.36%) M. Cap (Cr) 1.75 1 Yr Return (%) NaN% P/E (TTM) 18.05 PB Ratio 3.19
Stock Name Oxygenta Pharmaceutical Ltd ₹48.25 (+4.32%) M. Cap (Cr) 1.78 1 Yr Return (%) -57.68% P/E (TTM) -10.18 PB Ratio -4.19
Stock Name Parnax Lab Ltd ₹142.70 (-1.92%) M. Cap (Cr) 1.64 1 Yr Return (%) +37.34% P/E (TTM) 13.92 PB Ratio 1.72
Stock Name Bio Medica Laboratories Ltd ₹130.00 (+0.27%) M. Cap (Cr) 1.63 1 Yr Return (%) NaN% P/E (TTM) 62.13 PB Ratio 9.17
Stock Name Panchsheel Organics Ltd ₹122.40 (-0.65%) M. Cap (Cr) 1.61 1 Yr Return (%) -16.05% P/E (TTM) 14.89 PB Ratio 1.14
Oxygenta Pharmaceutical Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Oxygenta Pharmaceutical Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -27.75 Mar 2025 2.60 Mar 2024 -13.05 Mar 2023 -1.63 Mar 2022 -1.68
PARTICULARS Investing Activities Mar 2026 -14.39 Mar 2025 -11.25 Mar 2024 -4.09 Mar 2023 -9.64 Mar 2022 -4.94
PARTICULARS Financing Activities Mar 2026 42.56 Mar 2025 8.67 Mar 2024 17.13 Mar 2023 11.22 Mar 2022 6.33
PARTICULARS Net Cash Flow Mar 2026 0.42 Mar 2025 0.02 Mar 2024 -0.01 Mar 2023 -0.05 Mar 2022 -0.29
Oxygenta Pharmaceutical Ltd Shareholding Pattern
This shows the ownership breakdown of Oxygenta Pharmaceutical Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990. The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited. Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. Apart from these, it is doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from Q-Acid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. This contract manufacturing helped the Company to meet major operational expenses. Since the Company started commercial production in July, 2015 after fire accident tragedy, it is in process of stabilizing the manufacturing and marketing.
Chairman & Managing Director
Sai Sudhakar Vankineni
Registered office Survey No 252/1 Aroor Village, Sadasivapet Mandal, Medak, Telangana, 502291
FAX :91-08455-250080/250280
Background
Incorporation Year 1990
Face Value ₹10.00
Market Lot 100
FAQs on Oxygenta Pharmaceutical Ltd
How to buy Oxygenta Pharmaceutical Ltd shares?
To buy Oxygenta Pharmaceutical Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Oxygenta Pharmaceutical Ltd?
The company has a market capitalization of ₹178.45.
What is the PE & PB ratio of Oxygenta Pharmaceutical Ltd?
PE is N/A and PB is -4.008.
What is the Oxygenta Pharmaceutical Ltd dividend for 2025–26?
For the 2025–26 financial year, Oxygenta Pharmaceutical Ltd declared a final dividend of null% per share.